1. Home
  2. MAIN vs PTCT Comparison

MAIN vs PTCT Comparison

Compare MAIN & PTCT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Main Street Capital Corporation

MAIN

Main Street Capital Corporation

SELL

Current Price

$53.22

Market Cap

4.8B

Sector

Finance

ML Signal

SELL

Logo PTC Therapeutics Inc.

PTCT

PTC Therapeutics Inc.

HOLD

Current Price

$60.97

Market Cap

5.5B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
MAIN
PTCT
Founded
2007
1998
Country
United States
United States
Employees
N/A
N/A
Industry
Finance/Investors Services
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
4.8B
5.5B
IPO Year
2014
2006

Fundamental Metrics

Financial Performance
Metric
MAIN
PTCT
Price
$53.22
$60.97
Analyst Decision
Hold
Buy
Analyst Count
8
16
Target Price
$59.86
★ $97.81
AVG Volume (30 Days)
431.7K
★ 948.0K
Earning Date
11-05-2026
10-29-2026
Dividend Yield
★ 8.19%
N/A
EPS Growth
N/A
★ 264.48
EPS
★ 0.93
0.90
Revenue
N/A
★ $264,734,000.00
Revenue This Year
$3.50
N/A
Revenue Next Year
$7.32
$9.52
P/E Ratio
★ $57.50
$67.58
Revenue Growth
N/A
★ 36.19
52 Week Low
$48.95
$58.80
52 Week High
$65.23
$90.87

Technical Indicators

Market Signals
Indicator
MAIN
PTCT
Relative Strength Index (RSI) 40.53 40.93
Support Level $52.47 $58.80
Resistance Level $54.88 $69.62
Average True Range (ATR) 0.90 2.04
MACD 0.03 0.20
Stochastic Oscillator 40.49 30.36

Price Performance

Historical Comparison
MAIN
PTCT

About MAIN Main Street Capital Corporation

Main Street Capital Corp is a principal investment firm focused on providing customized long-term debt and equity capital solutions to lower middle market ("LMM") companies and debt capital to private ("Private Loan") companies owned by or in the process of being acquired by a private equity fund. The group invests principally in secured debt investments, equity investments, warrants, and other securities of LMM companies, typically based in the U.S. The company operates as a single segment with a principal investment objective to maximize total return by generating current income from debt investments and current income and capital appreciation from equity and equity-related investments.

About PTCT PTC Therapeutics Inc.

PTC Therapeutics Inc is a biopharmaceutical company that discovers, develops and commercializes clinically differentiated medicines that provide benefits to children and adults living with rare disorders. Its diversified therapeutic portfolio that includes several commercial products and product candidates in various stages of development, including discovery, research and clinical stages, focused on the development of new treatments for multiple therapeutic areas for rare diseases relating to neurology and metabolism. The company views its operations and manages its business in one operating segment: life science, which is focused on the discovery, development and commercialization of the company's clinically differentiated medicines that provide benefits to patients with rare disorders.

Share on Social Networks: